Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
BMJ Case Rep ; 14(7)2021 Jul 29.
Article in English | MEDLINE | ID: mdl-34326107

ABSTRACT

Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged.


Subject(s)
Asthma , Churg-Strauss Syndrome , Granulomatosis with Polyangiitis , Asthma/drug therapy , Churg-Strauss Syndrome/chemically induced , Churg-Strauss Syndrome/diagnosis , Granulomatosis with Polyangiitis/complications , Granulomatosis with Polyangiitis/drug therapy , Humans , Immunosuppressive Agents , Omalizumab/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL